BIOMERICA INC Increase (Decrease) in Other Noncurrent Assets
BIOMERICA INC (BMRA) reported Increase (Decrease) in Other Noncurrent Assets of -$2.77 thousand for the 9-month period ending 2013-02-28, per its 10-Q filed 2013-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2013-04-15
- BIOMERICA INC increase (decrease) in other noncurrent assets for the quarter ending 2012-05-31 was -$25.01K, a 342.68% decline year-over-year.
- BIOMERICA INC increase (decrease) in other noncurrent assets for the quarter ending 2011-05-31 was $10.31K.
- BIOMERICA INC increase (decrease) in other noncurrent assets for fiscal 2012 was -$30.67K, a 196.20% decline from fiscal 2011.
- BIOMERICA INC increase (decrease) in other noncurrent assets for fiscal 2011 was $31.89K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|
| 2013-02-28 | -$2.77K 10-Q · filed 2013-04-15 | ||
| 2012-05-31 | -$25.01K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | -$30.67K 10-K · filed 2012-08-29 | |
| 2012-02-29 | -$5.66K 10-Q · filed 2013-04-15 | ||
| 2011-05-31 | $10.31K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $31.89K 10-K · filed 2012-08-29 | |
| 2011-02-28 | $21.58K 10-Q · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |